Epidemiology, prevention, and early detection of breast cancer - PubMed (original) (raw)
Review
Epidemiology, prevention, and early detection of breast cancer
A J Alberg et al. Curr Opin Oncol. 1999 Nov.
Abstract
Globally, breast cancer is the third most common form of cancer and the most common among women. The age-adjusted incidence rates of breast cancer are 176% higher in developed than in developing nations. Male breast cancer is rare, but important studies provided risk factor information for comparison with studies of female breast cancer. There has been considerable interest in a possible role of organochlorines and polychlorinated biphenyls in the etiology of breast cancer, but the results of several null studies indicate the likelihood of such associations is extremely remote, providing reassuring news for the public. Prophylactic mastectomy was observed to significantly reduce a woman's chances of developing breast cancer, but it does not lower the risk to zero. Tamoxifen was found to be an effective chemopreventive agent in the Breast Cancer Prevention Trial, but this result was not replicated in two randomized trials in Europe. Striking reductions in the risk for breast cancer were observed for raloxifene in a randomized, placebo-controlled trial that had been designed for the prevention of osteoporosis. A large-scale, randomized trial of tamoxifen-verus-raloxifene among women at increased risk for developing breast cancer is now underway.
Similar articles
- American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
Chlebowski RT, Collyar DE, Somerfield MR, Pfister DG. Chlebowski RT, et al. J Clin Oncol. 1999 Jun;17(6):1939-55. doi: 10.1200/JCO.1999.17.6.1939. J Clin Oncol. 1999. PMID: 10561236 Review. - Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
Crowell EB Jr, Jubelirer SJ. Crowell EB Jr, et al. W V Med J. 2000 Nov-Dec;96(6):598-601. W V Med J. 2000. PMID: 11194088 - Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, Neugut AI. Grann VR, et al. Cancer J Sci Am. 2000 Jan-Feb;6(1):13-20. Cancer J Sci Am. 2000. PMID: 10696733 - Epidemiology, prevention, and early detection of breast cancer.
Alberg AJ, Visvanathan K, Helzlsouer KJ. Alberg AJ, et al. Curr Opin Oncol. 1998 Nov;10(6):492-7. doi: 10.1097/00001622-199811000-00003. Curr Opin Oncol. 1998. PMID: 9818226 Review. - Overview of the main outcomes in breast-cancer prevention trials.
Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P. Cuzick J, et al. Lancet. 2003 Jan 25;361(9354):296-300. doi: 10.1016/S0140-6736(03)12342-2. Lancet. 2003. PMID: 12559863 Review.
Cited by
- Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women.
Floris M, Pira G, Castiglia P, Idda ML, Steri M, De Miglio MR, Piana A, Cossu A, Azara A, Arru C, Deiana G, Putzu C, Sanna V, Carru C, Serra A, Bisail M, Muroni MR. Floris M, et al. Oncol Lett. 2022 Aug 8;24(4):331. doi: 10.3892/ol.2022.13451. eCollection 2022 Oct. Oncol Lett. 2022. PMID: 36039053 Free PMC article. - Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin.
Chisholm CL, Wang H, Wong AH, Vazquez-Ortiz G, Chen W, Xu X, Deng CX. Chisholm CL, et al. Oncotarget. 2016 Dec 20;7(51):84439-84452. doi: 10.18632/oncotarget.12992. Oncotarget. 2016. PMID: 27806319 Free PMC article. - High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: developing a pig model for breast cancer.
Luo Y, Li J, Liu Y, Lin L, Du Y, Li S, Yang H, Vajta G, Callesen H, Bolund L, Sørensen CB. Luo Y, et al. Transgenic Res. 2011 Oct;20(5):975-88. doi: 10.1007/s11248-010-9472-8. Epub 2010 Dec 22. Transgenic Res. 2011. PMID: 21181439 - Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.
Wang RH, Zheng Y, Kim HS, Xu X, Cao L, Luhasen T, Lee MH, Xiao C, Vassilopoulos A, Chen W, Gardner K, Man YG, Hung MC, Finkel T, Deng CX. Wang RH, et al. Mol Cell. 2008 Oct 10;32(1):11-20. doi: 10.1016/j.molcel.2008.09.011. Mol Cell. 2008. PMID: 18851829 Free PMC article. - BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution.
Deng CX. Deng CX. Nucleic Acids Res. 2006 Mar 6;34(5):1416-26. doi: 10.1093/nar/gkl010. Print 2006. Nucleic Acids Res. 2006. PMID: 16522651 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical